Screener
Upstream Bio, Inc. UPB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | 7 | (50) | (23) | (50) |
| Total other income, net | 2,666 | 4,381 | 5,690 | 9,124 |
| Net loss | $(39,702) | $(39,966) | $(80,293) | $(67,236) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.73) | $(0.74) | $(1.47) | $(1.25) |
| Weighted-average common shares outstanding, basic and diluted | 54,567,976 | 53,770,868 | 54,450,798 | 53,694,424 |
| Comprehensive loss: | ||||
| Net loss | $(39,702) | $(39,966) | $(80,293) | $(67,236) |
| Unrealized gain (loss) on investments, net of tax | (223) | (110) | (653) | 283 |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s EPS (diluted)?
- Upstream Bio, Inc. (UPB) reported EPS (diluted) of -$0.73 in Q2 2026.
- How has Upstream Bio, Inc.'s EPS (diluted) changed year-over-year?
- Upstream Bio, Inc.'s EPS (diluted) increased by 1.4% year-over-year, from -$0.74 to -$0.73.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Upstream Bio, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude